The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Depression and Clinical Progression in HIV-Infected Drug Users Treated with Highly Active Antiretroviral Therapy
Open accessAbstract
Objective: To disentangle the impact of adherence from that of injecting drug status and depressive syndrome on HIV clinical progression in a cohort of highly active anti-retroviral therapy (HAART)-treated HIV patients infected through drug use. Design: MANIF 2000 is a French cohort of HIV-infected drug users with scheduled medical visits every 6 months. Only patients enrolled in the MANIF 2000 cohort who had a CD4 cell count >200 cells/μl at HAART initiation were selected. The follow-up period included all post-HAART initiation visits. Methods: HIV clinical progression was defined as either AIDS-related death or reaching a CD4 level <200 cells/μl. Adherence was assessed using a self-administered questionnaire and a structured face-to-face interview. Depressive symptoms were evaluated by a Center for Epidemiologic Studies Depression Scale (CES-D) score at each visit. Cox proportional hazards model was used to calculate crude and adjusted relative hazards and 95% confidence intervals and thus identify independent predictors of clinical progression. Results: Of the 305 HAART-treated patients in the cohort, 243 had CD4 cell count >200 cells/μl at HAART initiation. At the first visit after HAART initiation, median CD4 cell count was 466 cells/μl and 45% had undetectable viral load. Injecting drug users accounted for 17% of the study group. Over the follow-up period, 32 patients experienced HIV clinical progression. Probable depression was encountered in 46% of patients and non-adherence in 31% of the sample. After adjustment on baseline CD4 cell count, predictors of clinical progression were: having a higher level of cumulative non-adherence over the follow-up period [HR (95% CI)=1.2 (1.1–1.3) per 10% increase] and having a high score of depressive symptoms following HAART initiation [HR (95% CI)=5.3 (2.21–3.0)]. Conclusions: Although depressive syndrome is known to influence non-adherence behaviours that are amongst the major reasons for clinical progression, it is also a predictor of clinical progression in HIV-infected intravenous drug users on HAART, independently of non-adherence behaviours. HIV care providers should be more sensitive to depressive symptoms in order to detect them early and supply HIV patients with specific care. Further research is needed to determine whether treating depressive symptoms may improve adherence and thus delay disease progression and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Self-report among injecting drug users: A review
Darke, S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00028-3 · Cited by 1,141
Case-Finding Instruments for Depression in Primary Care Settings
Mulrow, C. D., Williams, J. W., Gerety, M. B., Ramirez, G., Montiel, O. M., & Kerber, C. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-12-199506150-00004 · Cited by 456 · cited 1×
“Thus we may have overestimated the proportion of patients with depression [54,55].”
Background
Cited by
Role of depression, stress, and trauma in HIV disease progression
Leserman, J. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181777a5f · Cited by 662
“Depression at initial HAART use was associated with: a) over five times the risk of clinical progression to AIDS (30), b) slower virologic suppression (31), and c) shorter survival (32).”
BackgroundDepression in HIV Infected Patients: a Review
Nanni, M. G., Caruso, R., Mitchell, A. J., Meggiolaro, E., & Grassi, L. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0530-4 · Cited by 511
Chander, G., Himelhoch, S., & Moore, R. D. (2006) · Drugs · doi:10.2165/00003495-200666060-00004 · Cited by 379
HIV and depression: 2008 review and update
Rabkin, J. G. (2008) · Current HIV/AIDS Reports · doi:10.1007/s11904-008-0025-1 · Cited by 347
Malta, M., Strathdee, S. A., Magnanini, M. M. F., & Bastos, F. I. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02269.x · Cited by 283
Metadata
- Authors
- the MANIF 2000 Study Group, Bouhnik, A.-D., Préau, M., Vincent, E., Carrieri, M. P., Gallais, H., Lepeu, G., Gastaut, J.-A., Moatti, J.-P., & Spire, B.
- Venue
- Antiviral Therapy
- Publisher
- SAGE Publications
- Published
- 2005-01
- Volume
- 10
- Issue
- 1
- Pages
- 53-61
- ISSN
- 1359-6535 (ISSN-L)
- 2040-2058
- OpenAlex
- W135177822
- Cited by
- 182
- References
- 2
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression and Clinical Progression in HIV-Infected Drug Users Treated with Highly Active Antiretroviral Therapy. https://app.cochat.ai/papers/10.1177/135965350501000103
- The paper
- the MANIF 2000 Study Group, Bouhnik, A.-D., Préau, M., Vincent, E., Carrieri, M. P., Gallais, H., Lepeu, G., Gastaut, J.-A., Moatti, J.-P., & Spire, B. (2005). Depression and Clinical Progression in HIV-Infected Drug Users Treated with Highly Active Antiretroviral Therapy. Antiviral Therapy. https://doi.org/10.1177/135965350501000103
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.